The Appraisal of Clinical Practice Guidelines for Breast Cancer-Related Lymphedema
Lymphatic Research and Biology · 2023
DOI: 10.1089/lrb.2022.0090 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Lymphatic Research and Biology, 2023. Verfasst von Naomi D Dolgoy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Therapy, Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Canada. Hauptthemen laut MEDLINE: Practice Guidelines as Topic, Breast Cancer Lymphedema, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Approaches to screening, assessment, and treatment of breast cancer-related lymphedema (BCRL) vary widely. We evaluated overall quality of clinical practice guidelines (CPGs) for managing BCRL using the Appraisal of Guidelines for REsearch and Evaluation II (AGREE II) tool, and relevance of consensus recommendations for the Canadian health context. Methods and Results: We searched electronic databases, gray literature, national lymphedema frameworks, and expert opinions, to identify lymphedema CPGs, printed/published from January 2013 to October 2021. Using AGREE II, six health care professionals reviewed CPGs for consensus. Domain-specific AGREE II quality consensus scores were required (≥70% for Rigor of Development; ≥ 60% for Stakeholder Involvement and Editorial Independence; and ≥50% for Clarity of Presentation, Applicability, Scope, and Purpose). Results and overall recommendations from the CPGs were summarized and synthesized. Nine CPGs met inclusion criteria for review. Wide variability of evidence-based recommendations, and limited clinical considerations were found. Scope and Purpose, and Clarity of Presentation were adequate in six of nine CPGs; Stakeholder Involvement in seven of nine CPGs; and Editorial Independence in three of nine CPGs. Across all CPGs, Applicability was minimally reported. Only the Queensland Health CPG met quality consensus scores for Rigor and Development; however, the focus was limited to compression therapy.
Conclusions
No CPG reviewed could be adopted for the Canadian health context. The proposed Canadian BCRL CPG will focus on stakeholder engagement, methodology, and implementation/evaluation. Using AGREE II allowed for assessment of quality of methods used to develop identified CPGs from other countries before consideration of adoption in a Canadian Context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physical Therapy, Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Canada.
- Sidekick Health, Kopavogur, Iceland.
- Rehabilitation Oncology, Holy Cross Site, Cancer Care Alberta, Alberta Health Services, Calgary, Canada.
- Scott Health Sciences Library, University of Alberta, Edmonton, Canada.
- Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
- Patient Representative, Vancouver, Canada.
Zitieren
APA
Dolgoy, N. D., Al Onazi, M. M., Parkinson, J. F., Gudmundsson, H., Radke, L. L., Dennett, L., Campbell, K. L., Harris, S. R., Keast, D., & McNeely, M. L. (2023). The Appraisal of Clinical Practice Guidelines for Breast Cancer-Related Lymphedema. Lymphatic Research and Biology. https://doi.org/10.1089/lrb.2022.0090
Vancouver
Dolgoy ND, Al Onazi MM, Parkinson JF, Gudmundsson H, Radke LL, Dennett L, et al. The Appraisal of Clinical Practice Guidelines for Breast Cancer-Related Lymphedema. Lymphatic Research and Biology. 2023. doi:10.1089/lrb.2022.0090
BibTeX
@article{Dolgoy2023,
author = {Dolgoy, Naomi D and Al Onazi, Mona M and Parkinson, Joanna F and Gudmundsson, Haukur and Radke, Lori L and Dennett, Liz and Campbell, Kristin L and Harris, Susan R and Keast, David and McNeely, Margaret L},
title = {The Appraisal of Clinical Practice Guidelines for Breast Cancer-Related Lymphedema},
journal = {Lymphatic Research and Biology},
year = {2023},
doi = {10.1089/lrb.2022.0090}
}
EUVIMED